LON:CSRT

Consort Medical plc (CSRT.L) Stock Chart and Price History

GBX 1,010

+5.00 (+0.50%)

(As of 03/5/2020)

Add

Compare

Today's Range: 1,005
▼
1,010
50-Day Range: 1,010
▼
1,010
52-Week Range: 702
▼
1,075

Volume: 768 shs
Average Volume: 520,697 shs
Market Capitalization: £504.60 million

P/E Ratio: 127.85
Dividend Yield: 2.75%
Beta: N/A

Consort Medical plc (CSRT.L) (LON:CSRT) Price Performance

5 Day Performance: 0.00%
1 Month Performance: 0.00%
3 Month Performance: 0.00%
Year-To-Date Performance: 0.00%
1 Year Performance: 0.00%

Consort Medical plc (CSRT.L) (LON CSRT) Stock Chart for Thursday, May, 19, 2022

Charts Provided by TradingView.

Consort Medical plc (CSRT.L) (LON:CSRT) Price History

Time Frame

Start Date

End Date

Export to Excel

Date	Opening Price	Closing Price	High	Low	Volume	Market Capitalization
05/18/2022	GBX 1,010	GBX 1,010	GBX 1,010	GBX 1,005	768 shs	£504.60 million
05/17/2022	N/A	GBX 1,010	GBX 1,010	GBX 1,005	768 shs	£504.60 million
05/13/2022	N/A	GBX 1,010	GBX 1,010	GBX 1,005	768 shs	£504.60 million
05/11/2022	GBX 1,010	GBX 1,010	GBX 1,010	GBX 1,005	768 shs	£504.60 million
05/10/2022	GBX 1,010	GBX 1,010	GBX 1,010	GBX 1,005	768 shs	£504.60 million
05/09/2022	GBX 1,010	GBX 1,010	GBX 1,010	GBX 1,005	768 shs	£504.60 million
05/06/2022	GBX 1,010	GBX 1,010	GBX 1,010	GBX 1,005	768 shs	£504.60 million
05/05/2022	GBX 1,010	GBX 1,010	GBX 1,010	GBX 1,005	768 shs	£504.60 million
05/04/2022	GBX 1,010	GBX 1,010	GBX 1,010	GBX 1,005	768 shs	£504.60 million
05/03/2022	GBX 1,010	GBX 1,010	GBX 1,010	GBX 1,005	768 shs	£504.60 million

05/02/2022	N/A	GBX 1,010	GBX 1,010	GBX 1,005	768 shs	£504.60 million
04/29/2022	GBX 1,010	GBX 1,010	GBX 1,010	GBX 1,005	768 shs	£504.60 million
04/28/2022	GBX 1,010	GBX 1,010	GBX 1,010	GBX 1,005	768 shs	£504.60 million
04/27/2022	GBX 1,010	GBX 1,010	GBX 1,010	GBX 1,005	768 shs	£504.60 million
04/26/2022	GBX 1,010	GBX 1,010	GBX 1,010	GBX 1,005	768 shs	£504.60 million
04/25/2022	N/A	GBX 1,010	GBX 1,010	GBX 1,005	768 shs	£504.60 million
04/22/2022	GBX 1,010	GBX 1,010	GBX 1,010	GBX 1,005	768 shs	£504.60 million
04/21/2022	GBX 1,010	GBX 1,010	GBX 1,010	GBX 1,005	768 shs	£504.60 million
04/20/2022	GBX 1,010	GBX 1,010	GBX 1,010	GBX 1,005	768 shs	£504.60 million
04/19/2022	GBX 1,010	GBX 1,010	GBX 1,010	GBX 1,005	768 shs	£504.60 million
04/18/2022	N/A	GBX 1,010	GBX 1,010	GBX 1,005	768 shs	£504.60 million
04/15/2022	GBX 1,010	GBX 1,010	GBX 1,010	GBX 1,005	768 shs	£504.60 million
04/14/2022	GBX 1,010	GBX 1,010	GBX 1,010	GBX 1,005	768 shs	£504.60 million
04/13/2022	GBX 1,010	GBX 1,010	GBX 1,010	GBX 1,005	768 shs	£504.60 million
04/12/2022	GBX 1,010	GBX 1,010	GBX 1,010	GBX 1,005	768 shs	£504.60 million
04/11/2022	N/A	GBX 1,010	GBX 1,010	GBX 1,005	768 shs	£504.60 million
04/08/2022	N/A	GBX 1,010	GBX 1,010	GBX 1,005	768 shs	£504.60 million
04/06/2022	GBX 1,010	GBX 1,010	GBX 1,010	GBX 1,005	768 shs	£504.60 million
04/05/2022	GBX 1,010	GBX 1,010	GBX 1,010	GBX 1,005	768 shs	£504.60 million
04/04/2022	N/A	GBX 1,010	GBX 1,010	GBX 1,005	768 shs	£504.60 million
04/01/2022	GBX 1,010	GBX 1,010	GBX 1,010	GBX 1,005	768 shs	£504.60 million
03/31/2022	GBX 1,010	GBX 1,010	GBX 1,010	GBX 1,005	768 shs	£504.60 million
03/30/2022	GBX 1,010	GBX 1,010	GBX 1,010	GBX 1,005	768 shs	£504.60 million
03/29/2022	GBX 1,010	GBX 1,010	GBX 1,010	GBX 1,005	768 shs	£504.60 million
03/28/2022	N/A	GBX 1,010	GBX 1,010	GBX 1,005	768 shs	£504.60 million
03/25/2022	GBX 1,010	GBX 1,010	GBX 1,010	GBX 1,005	768 shs	£504.60 million
03/24/2022	GBX 1,010	GBX 1,010	GBX 1,010	GBX 1,005	768 shs	£504.60 million
03/23/2022	GBX 1,010	GBX 1,010	GBX 1,010	GBX 1,005	768 shs	£504.60 million
03/22/2022	GBX 1,010	GBX 1,010	GBX 1,010	GBX 1,005	768 shs	£504.60 million
03/21/2022	N/A	GBX 1,010	GBX 1,010	GBX 1,005	768 shs	£504.60 million
03/18/2022	GBX 1,010	GBX 1,010	GBX 1,010	GBX 1,005	768 shs	£504.60 million
03/18/2022	GBX 1,010	GBX 1,010	GBX 1,010	GBX 1,005	768 shs	£504.60 million
03/17/2022	GBX 1,010	GBX 1,010	GBX 1,010	GBX 1,005	768 shs	£504.60 million
03/16/2022	GBX 1,010	GBX 1,010	GBX 1,010	GBX 1,005	768 shs	£504.60 million
03/15/2022	GBX 1,010	GBX 1,010	GBX 1,010	GBX 1,005	768 shs	£504.60 million
03/14/2022	N/A	GBX 1,010	GBX 1,010	GBX 1,005	768 shs	£504.60 million
03/11/2022	GBX 1,010	GBX 1,010	GBX 1,010	GBX 1,005	768 shs	£504.60 million
03/10/2022	GBX 1,010	GBX 1,010	GBX 1,010	GBX 1,005	768 shs	£504.60 million
03/09/2022	N/A	GBX 1,010	GBX 1,010	GBX 1,005	768 shs	£504.60 million
03/07/2022	N/A	GBX 1,010	GBX 1,010	GBX 1,005	768 shs	£504.60 million
03/04/2022	GBX 1,010	GBX 1,010	GBX 1,010	GBX 1,005	768 shs	£504.60 million
03/03/2022	GBX 1,010	GBX 1,010	GBX 1,010	GBX 1,005	768 shs	£504.60 million
03/02/2022	GBX 1,010	GBX 1,010	GBX 1,010	GBX 1,005	768 shs	£504.60 million
03/01/2022	GBX 1,010	GBX 1,010	GBX 1,010	GBX 1,005	768 shs	£504.60 million
02/28/2022	N/A	GBX 1,010	GBX 1,010	GBX 1,005	768 shs	£504.60 million
02/25/2022	GBX 1,010	GBX 1,010	GBX 1,010	GBX 1,005	768 shs	£504.60 million
02/24/2022	GBX 1,010	GBX 1,010	GBX 1,010	GBX 1,005	768 shs	£504.60 million
02/23/2022	GBX 1,010	GBX 1,010	GBX 1,010	GBX 1,005	768 shs	£504.60 million
02/22/2022	GBX 1,010	GBX 1,010	GBX 1,010	GBX 1,005	768 shs	£504.60 million
02/21/2022	N/A	GBX 1,010	GBX 1,010	GBX 1,005	768 shs	£504.60 million
02/18/2022	GBX 1,010	GBX 1,010	GBX 1,010	GBX 1,005	768 shs	£504.60 million

This page was last updated on 5/19/2022 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Resources